Show simple item record

dc.contributor.authorLingasamy, Prakash
dc.contributor.authorTobi, Allan
dc.contributor.authorHaugas, Maarja
dc.contributor.authorHunt, Hedi
dc.contributor.authorPaiste, Paarn
dc.contributor.authorAsser, Toomas
dc.contributor.authorRatsep, Tonu
dc.contributor.authorKotamraju, Venkata Ramana
dc.contributor.authorBjerkvig, Rolf
dc.contributor.authorTeesalu, Tambet
dc.date.accessioned2020-03-25T12:41:21Z
dc.date.available2020-03-25T12:41:21Z
dc.date.issued2019
dc.identifier.citationLingasamy, Tobi, Haugas, Hunt, Paiste, Asser T, Ratsep, Kotamraju, Bjerkvig R, Teesalu. Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery. Biomaterials. 2019;219:119373eng
dc.identifier.urihttp://hdl.handle.net/1956/21587
dc.description.abstractOncofetal fibronectin (FN-EDB) and tenascin-C C domain (TNC-C) are nearly absent in extracellular matrix of normal adult tissues but upregulated in malignant tissues. Both FN-EDB and TNC-C are developed as targets of antibody-based therapies. Here we used peptide phage biopanning to identify a novel targeting peptide (PL1, sequence: PPRRGLIKLKTS) that interacts with both FN-EDB and TNC-C. Systemic PL1-functionalized model nanoscale payloads [iron oxide nanoworms (NWs) and metallic silver nanoparticles] homed to glioblastoma (GBM) and prostate carcinoma xenografts, and to non-malignant angiogenic neovessels induced by VEGF-overexpression. Antibody blockage experiments demonstrated that PL1 tumor homing involved interactions with both receptor proteins. Treatment of GBM mice with PL1-targeted model therapeutic nanocarrier (NWs loaded with a proapoptotic peptide) resulted in reduced tumor growth and increased survival, whereas treatment with untargeted particles had no effect. PL1 peptide may have applications as an affinity ligand for delivery of diagnostic and therapeutic compounds to microenvironment of solid tumors.eng
dc.language.isoengeng
dc.publisherElseviereng
dc.relation.urihttps://reader.elsevier.com/reader/sd/pii/S0142961219304727?token=FB229AC72E5587D1EE4F3B4298E4227FD6BEA06DC6CBEA7F960636C6E833AB604F2ACB373019A3E6DCAD29AB93640563
dc.rightsAttribution CC BY-NC-NDeng
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/eng
dc.titleBi-specific tenascin-C and fibronectin targeted peptide for solid tumor deliveryeng
dc.typeJournal articleeng
dc.date.updated2019-11-27T09:07:40Z
dc.rights.holderCopyright 2019 The Author(s)eng
dc.type.versionpublishedVersioneng
bora.peerreviewedPeer reviewedeng
dc.type.documentJournal article
dc.identifier.cristinID1729724
dc.identifier.doi10.1016/j.biomaterials.2019.119373eng
dc.source.issn0142-9612eng
dc.source.issn1878-5905eng
dc.relation.journalBiomaterials


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY-NC-ND
Except where otherwise noted, this item's license is described as Attribution CC BY-NC-ND